Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery
Completed
Conditions studied: Vascular Death, Myocardial Infarction, Stroke, Cardiac Surgery
In brief
Worldwide over 2 million adults (\>30,000 Canadians) undergo heart surgery annually. Although heart surgery provides important survival benefits, it is associated with potential major complications such as death, stroke, and heart attack. There is promising evidence that measurement of heart injury markers after surgery will identify patients at risk of death or major complications. This study will determine the current incidence of major complications in a representative sample of 15,000 contemporary adult patients undergoing heart surgery. Knowing the current burden of complications will inform clinicians, administrators, government and granting agencies about resources required to address the problem. This study will also establish the role of measuring heart injury markers to identify important heart injury after heart surgery and the proportion that would go undetected without routine heart injury marker monitoring. This information will facilitate further studies of timely interventions. In summary, the VISION Cardiac Surgery Study addresses fundamental questions that will have profound public health implications given the millions of adults worldwide who undergo heart surgery annually.
Key facts
- Study ID
- NCT01842568
- Run by
- Population Health Research Institute
- People needed
- 15989
- Starts
- 2013-05-01
- Expected to finish
- 2025-07-01
- Last updated by the study team
- 2025-07-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years.
- Patients who have undergone cardiac surgery. This includes coronary artery bypass grafting and all open heart procedures such as valvular repairs/replacement.
You may not qualify if…
- Previously enrolled in the VISION Cardiac Surgery Study.
- Patients who have undergone an isolated pericardial window, pericardiectomy, permanent pacemaker or defibrillator implantation.
Where it is running
- Ronald Reagan Medical Centre, UCLA — Los Angeles, California, United States
- Royal Prince Alfred Hospital — Sydney, New South Wales, Australia
- Hospital de Clínicas de Porto Alegre - HCPA — Porto Alegre, Rio Grande do Sul, Brazil
- Instituto de Cardiologia do RS — Porto Alegre, Rio Grande do Sul, Brazil
- INCOR — São Paulo, Brazil
- Hamilton Health Sciences — Hamilton, Ontario, Canada
- Kingston General Hospital — Kingston, Ontario, Canada
- Sunnybrook Health Sciences Centre — Toronto, Ontario, Canada
- First Teaching Hospital — Xinjiang, China
- Prince of Wales Hospital — Shatin, Hong Kong, SAR, Hong Kong
- Santa Maria Hospital, GVM Care and Research — Bari, Italy
- University of Bari "Aldo Moro" — Bari, Italy
- San Raffaele Scientific Institute — Milan, Italy
- Institut Jantung Negara Sdn. Bhd. — Kuala Lumpur, Malaysia
- University of Malaya Medical Centre — Kuala Lumpur, Malaysia
- Department of Cardiovascular Surgery, Medical University of Gdansk — Gdansk, Poland
- Federal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Diseases" — Kemerovo, Russia
- Research Institute of Circulation Pathology — Novosibirsk, Russia
- Hospital de la Santa Creu i Sant Pau — Barcelona, Spain
- Essex Cardiothoracic Centre, Basildon and Thurrock University NHS Trust — Basildon, Essex, United Kingdom
- Blackpool Teaching Hospitals NHS Foundation Trust — Blackpool, Lancashire, United Kingdom
- Liverpool Heart and Chest Hospital NHS Foundation Trust — Liverpool, Merseyside, United Kingdom
- BHF Centre of Cardiovascular Science, University of Edinburgh — Edinburgh, United Kingdom
- New Cross Hospital — Wolverhampton, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.